Efficacy of Transcatheter Arterial Infusion Alone or Combined with Transcatheter Arterial Chemoembolization on Advanced Hepatocellular Carcinoma

Hao, Mingzhi; Lin, Hai; Chen, Qizhong; Yu, Weiyang

doi:10.4172/1948-5956.1000074

Cited by 6 publications

(7 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, a class of drug called MEK inhibitors is currently in clinical trials for different types of cancer. Chemoembolization which is a combination of chemotherapy and embolization uses drugs that are directly injected into the blood vessel feeding the cancer tissue and are mostly limited to hepatocellular carcinoma [39].…”

Section: Targeted Cancer Therapiesmentioning

confidence: 99%

A Compendium of Cancer Therapeutic Strategies and their Modality

N¹,

D²

2011

J Cancer Sci Ther

View full text Add to dashboard Cite

The main objective of cancer therapy is to prop up the death of cancer cells without any damage to surrounding healthy tissue. Our knowledge of molecular changes in cancer cells has enhanced the development of various therapeutic strategies to treat cancer cells. Now we are in an ideal position to utilize our knowledge of cancer cell biology in the designing of novel cancer therapies. This review is to highlight various specific and selective approaches (Chemotherapy, Radiotherapy, Surgery, Biological therapy) to understand its modality and current progress in cancer treatment.

show abstract

Section: Targeted Cancer Therapiesmentioning

confidence: 99%

A Compendium of Cancer Therapeutic Strategies and their Modality

N¹,

D²

2011

J Cancer Sci Ther

View full text Add to dashboard Cite

show abstract

“…Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world, and the third commonest cause of cancer mortality worldwide [22]. Hepatocellular carcinoma (HCC, also called malignant hepatoma) is the most common type of liver cancer (primary hepatic malignancy) in the Asian countries.…”

Section: Liver Cancermentioning

confidence: 99%

“…The portal vein thrombosis and ECOG PS were independent prognostic factors for overall survival (OS). Interventional treatment could greatly prolong the OS of advanced HCC patients [22].…”

Section: Liver Cancermentioning

confidence: 99%

Organ Specific Cancers - Recent Advances in Diagnosis and Treatment

Shalini¹,

RS²,

Gayathri³

et al. 2011

J Cancer Sci Ther

View full text Add to dashboard Cite

Cancer is one of the leading causes of death all over the world. Organ Specific Cancers are cancers named baseing on the location of cancer in the body organ. Its incidence is showing an increasing trend in various parts of the earth and has been a significant public health problem despite advances in the understanding of the molecular and cellular events that underlie. This review aims to update the current related information about organ specific cancers and provide a further understanding about their diagnosis and treatment.

show abstract

“…FIR will serve as a tool against diseases induced by HepG2 [69]. Efficacy of transcatheter arterial infusion (TAI) alone or combined with transcatheter arterial chemoembolization (TACE) on advanced hepatocellular carcinoma (HCC) [70].…”

Section: Recent Advances In Treatment Of Breast and Prostate Cancermentioning

confidence: 99%